Introduction:
In the second paragraph, you mention a rise of more than 120% in prescriptions of bisphosphonates over a ten-year period and attribute this to the rising proportion of elderly people in UK society. Looking at the numbers, I think there must be other additional reasons. I have some doubt (without having looked at demographic statistics in detail) that the proportion of elderly has more than doubled in ten years? On page 5 (line 25/26), you talk about the relative risk of the development of BRONJ that should be included into patient and health professional education. First, I would speak only of "risk" here and not "relative risk" (as no RR data is given). Another problem with more health education on this point is certainly the low incidence: considering the data, health professionals might decide that the risk of about 10 in a million is so small that they will probably never see a patient with this complication in their practice during their professional life. This is a universal problem: how do you raise awareness (and: should you do so?) for rare but severe complications of a drug, as doctors and patients are only able to remember -and digest -a limited amount of information and, as you discuss later on, have to prioritize. Explicitly pointing out rare side effects to the patient might also create adherence problems, as they will be afraid of complications they will probably never experience. This dilemma could be worth some discussion in your article. On page 12, you actually report a pharmacist`s statement mentioning possible compliance issues. The prevention aspect is important here: is there any data on how many cases of BRONJ could actually be prevented by better dental care and/or special awareness? If the risk were easily preventable by simple measures (however small the risk), education would make a lot of sense. You mention the rationale for optimizing dental care on page 5, but the actual benefit of such measures of prevention is not quantified here.
Method:
In the Design and Analysis sections, you describe the process of topic guide creation, refinement and identification of salient themes. This is presented in quite a short manner and without any examples of interview guide / structure or analytic framework. This makes it difficult for the reader to actually understand your qualitative research process. Sampling is also described only cursorily; you should elaborate on your purposive sampling process and on how (and why) you subsequently recruited participants via snowball sampling. Otherwise, the reader will assume that it was in fact a convenience sample based on ready availability of teaching practices. Did you employ demographic or practice characteristics as sampling criteria?
Results:
The tables describing the sample cover some important aspects. However, standard parameters like age and gender are missing -or do you consider this unimportant -and if, why? Did you try to achieve some balanced distribution? Were the parameters reported important in your sampling strategy? On page 9 (and at other places in the manuscript) you state that all participants were aware of BRONJ as a complication of bisphosphonate therapy as you told them about it in the study information sheet. However, it is not clear whether this sheet was handed out directly before the interview of well in advance? If the latter was the case, participants could have even informed themselves about BRONJ before the interview and this could have greatly influenced their answers. Did you elaborate on the relatively low incidence of the complication in the information leaflet? Page 10, first sentence: I am not a native speaker of English, so I might be wrong -but shouldn`t "…and the significant morbidity that their patients…" rather read "…and the significant morbidity that her/his patients…" -as you are talking about one GP only here? Page 11, first paragraph: "participants placed importance specifically (…) and common side effects of bisphosphonates". Do I interpret this right: they do educate on common side effects but not BRONJ, as it is not common? Why would doctors actually counsel patients on dental health (as you elaborate on the same page) if they do not educate on BRONJ or are not even aware themselves? It is not exactly clear whether the cited comments on page 11/12 regarding oral health patient education and getting people to see their dentist were uttered in specific regard to the BRONJ topic or just as general remarks. Page 13: it would be worthwhile to elaborate a bit about the MUR and NMS Services for the non-UK reader, as an international audience might be somewhat at loss here.
Discussion:
In your "Summary of main findings" section, you mention the lack of inter-professional communication as a key issue/barrier (line 50 ff). But how could more communication -although always desirablealleviate the problem of low awareness for this comparably rare complication? You also state "…patient reluctance to attend the dentist and difficulties in accessing dental services were thought to be potential barriers for patients." But as awareness seems to be the key issue to me: why should a patient attend the dentist or even think about doing so, if neither his GP nor his pharmacists tells him about the necessity to do so, as they may not think about the complication or consider it unimportant? In the "Comparison with existing literature" section, you mention the general awareness of your patient population compared with Masson et al. (2009) . But as you informed your patients before the study, this is not really comparable to Masson`s data, and you should avoid talking about "In Comparison…" for something that cannot be compared. In the same section, you talk about a study from Japan in which 62% of physicians did not request oral examinations before commencing bisphosphonate therapy. This is interesting, as it means that actually 38% of doctors do so in Japan! Compared to the low awareness reported by Masson et al., Japanese doctors seem to think about BRONJ much more often. Why is this? It might also be worthwhile to include and discuss some more literature concerning other areas of physician-pharmacist collaboration, as there is a considerable body of international literature on this topic. Examples from other countries than the UK might also add more appeal for the international reader.
Limitations
For the third time in your manuscript, you mention the issue of introducing the topic to the participants in the information sheet. You state "…therefore potentially introducing the concept…". I would go as far as saying that you did most certainly introduce this concept to them (and not only potentially…) if they were unaware of it before.
Conclusion "…the incidence of BRONJ is likely to increase; this will continue to be the case unless changes are made to current practice and effective preventive measures are implemented". This statement sounds as if most cases of BRONJ would be potentially preventable -is this really true? As I mentioned above, it would be helpful to get some information about the actual effectiveness of preventive measures like dental care. generalize the data. Thirdly the interpretation of the results seems vague.
REVIEWER
Spyridon N. Papageorgiou Clinic of Orthodontics and Pediatric Dentistry Center of Dental Medicine, University of Zurich Zurich, Switzerland REVIEW RETURNED 13-Apr-2017
GENERAL COMMENTS Summary
The present study uses a qualitative approach to assess using semistructured interview the general practitioners and pharmacists" (n=17 total) attitudes and approach in the prevention of BROJN. I must admit I am not that familiar with this kind of mixed-methods semi-structured interview studies, but the study seems meticulously planned, analyzed and written. Judging from similar research articles published in the present or other peer-reviewed journals, the methodology used seems to be robust and adequate. Overall I think the present submission is nicely-written and I congratulate the authors on this.
Comment #1
Please explain all abbreviation at their first mention in every part of the manuscript. For example, the GP abbreviation in abstract is not explained.
Comment #2
Although I am not sure that this will add any substantial improvement to the existing tables (which are very informative and contain important participant characteristics), maybe the authors could nevertheless add the age and sex of included participants.
Comment #3
The results section is concisely written with careful selection of specific interesting statements from the participants" interviews.
Comment #4
The Discussion section likewise nicely develops on the themes emerged from the interviews, compares to existing studies on the field, and lists the limitations of the current work. I have nothing to comment here, except for a possible space issue, but if the editor clears this out, then I believe this could be left as it is.
Comment #5 A single comment: due to the nature of the analysis of acquired interviews (subjective selection of specific statements to be included in the text) I believe it could be of merit to interested readers to provide (probably as an online appendix) the full transcripts of all 17 participants. This will enable readers interested in this to further delve in the interviews and probably extract additional information on this subject.
REVIEWER

Elham Kateeb
Al-Quds University Jerusalem, Palestine REVIEW RETURNED 23-Apr-2017
GENERAL COMMENTS
The study is very important. The use of qualitative methodology added a value to the current research question. However, methodology was not discussed in adequate details to allow guiding other researchers in answering similar questions. Although analysis was adequately explained, questions asked to the sample were not mentioned. Items used in the mini-structure interview were not discussed. In addition, the authors mentioned that they used purposive sampling but they did not mention which subjects' characteristics they used to select their sample.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
Introduction:
In the second paragraph, you mention a rise of more than 120% in prescriptions of bisphosphonates over a ten-year period and attribute this to the rising proportion of elderly people in UK society. Looking at the numbers, I think there must be other additional reasons. I have some doubt (without having looked at demographic statistics in detail) that the proportion of elderly has more than doubled in ten years?
RESPONSE: Thank you for raising this important issue. We have rewritten this statement to state that this rise may be attributable to a number of factors, including an increasing elderly population, publication of guidance recommending bisphosphonate therapy and the availability of generic products. The paper has been updated by track changes, on page 4.
On page 5 (line 25/26), you talk about the relative risk of the development of BRONJ that should be included into patient and health professional education. First, I would speak only of "risk" here and not "relative risk" (as no RR data is given).
RESPONSE: The word "relative" has been removed from the updated manuscript. The paper has been updated on page 5 using track changes.
Another problem with more health education on this point is certainly the low incidence: considering the data, health professionals might decide that the risk of about 10 in a million is so small that they will probably never see a patient with this complication in their practice during their professional life. This is a universal problem: how do you raise awareness (and: should you do so?) for rare but severe complications of a drug, as doctors and patients are only able to remember -and digest -a limited amount of information and, as you discuss later on, have to prioritize. Explicitly pointing out rare side effects to the patient might also create adherence problems, as they will be afraid of complications they will probably never experience. This dilemma could be worth some discussion in your article. On page 12, you actually report a pharmacist`s statement mentioning possible compliance issues.
RESPONSE: This is an important discussion point that we have also considered at length. The incidence of BRONJ is certainly low; however it does cause very significant morbidity for the few patients who are unfortunate to suffer from this condition. We have therefore expanded on this issue and added to the discussion using Track Changes on page 20. The reviewer may also be interested to note that we are currently exploring this issue through a further study involving qualitative interviews with patients, including a number of patients who have a diagnosis of BRONJ. It is hoped that the findings from that study will shed some light on the perceptions of patients towards this issue and stimulate further debate in the literature which could also potentially be transferable to rare but severe side effects of other drugs
The prevention aspect is important here: is there any data on how many cases of BRONJ could actually be prevented by better dental care and/or special awareness? If the risk were easily preventable by simple measures (however small the risk), education would make a lot of sense. You mention the rationale for optimizing dental care on page 5, but the actual benefit of such measures of prevention is not quantified here.
RESPONSE: Thank you for highlighting this important point. There is a lack of literature that really addresses this question and this is certainly a question that should be addressed with further research. The consensus across the literature and in published guidelines is that prevention is the best course of action; in particular, because of the difficulties associated with treating the condition once it presents. There is evidence from prospective studies that preventive strategies have produced statistically significant reductions in incidence rates. The manuscript has been updated to address further this issue by track changes on page 5 and two additional reference sources have been used to support this information.
Method:
In the Design and Analysis sections, you describe the process of topic guide creation, refinement and identification of salient themes. This is presented in quite a short manner and without any examples of interview guide / structure or analytic framework. This makes it difficult for the reader to actually understand your qualitative research process.
RESPONSE: Thank you for this comment. In order to assist the reader, the interview topic guide has been provided as supplementary document. Interviews were semi-structured and the topic guide was used as a reference and prompt for the researcher.
Sampling is also described only cursorily; you should elaborate on your purposive sampling process and on how (and why) you subsequently recruited participants via snowball sampling. Otherwise, the reader will assume that it was in fact a convenience sample based on ready availability of teaching practices. Did you employ demographic or practice characteristics as sampling criteria?
RESPONSE: Thank you for your highlighting this. On reflection, the sampling strategy would be more accurately described as an initial convenience sample which was followed by a snowball sampling strategy. We have updated the manuscript on page 7 to more accurately explain the recruitment process. The invitation letter and participant information sheet has also been provided as a supplementary document.
Results:
The tables describing the sample cover some important aspects. However, standard parameters like age and gender are missing -or do you consider this unimportant -and if, why? Did you try to achieve some balanced distribution? Were the parameters reported important in your sampling strategy?
RESPONSE: The gender for each participant has been added to the results table. The age of the participants was not captured during the research process as this was felt not to be relevant; however the number of years of practicing experience was documented and is presented in the table. The table has been updated on page 9 of the manuscript using track changes On page 9 (and at other places in the manuscript) you state that all participants were aware of BRONJ as a complication of bisphosphonate therapy as you told them about it in the study information sheet. However, it is not clear whether this sheet was handed out directly before the interview of well in advance? If the latter was the case, participants could have even informed themselves about BRONJ before the interview and this could have greatly influenced their answers. Did you elaborate on the relatively low incidence of the complication in the information leaflet?
The participant information sheet was posted to all participants in advance of the interview. This has been highlighted further in the methodology section on page 7 . It is correct to say, therefore, that potentially participants could have informed themselves further on the topic in advance. However, the findings from this study demonstrated that there was a lack of knowledge about this condition amongst the participants, therefore even if participants did read about the topic in advance, there were still clear gaps in the knowledge base. The participant information sheet has been added as a supplementary document to this paper, and there was no explanation of the condition or incidence rates in the participant information leaflet.
Page 10, first sentence: I am not a native speaker of English, so I might be wrong -but shouldn`t "…and the significant morbidity that their patients…" rather read "…and the significant morbidity that her/his patients…" -as you are talking about one GP only here?
RESPONSE: Thank you. Yes, we have corrected this using track changes on page 10.
Page 11, first paragraph: "participants placed importance specifically (…) and common side effects of bisphosphonates". Do I interpret this right: they do educate on common side effects but not BRONJ, as it is not common?
RESPONSE: Yes, that is correct. Participants reported focusing on the administration instructions for the bisphosphonate and the more common side effects, such as GI or oesophageal problems. The manuscript has been updated using track changes on page 11 to expand on this in more details.
Why would doctors actually counsel patients on dental health (as you elaborate on the same page) if they do not educate on BRONJ or are not even aware themselves? It is not exactly clear whether the cited comments on page 11/12 regarding oral health patient education and getting people to see their dentist were uttered in specific regard to the BRONJ topic or just as general remarks.
RESPONSE: Yes, these were specific remarks in relation to BRONJ. Some of the participants who did have some awareness of BRONJ did advise patients to get dental check-ups. However, these participants commented that many of these patients in general did not appear to appreciate the importance of dental hygiene or oral health. This was also a common theme reported by participants in relation to patients" outlook on oral health issues as a whole and not just related to the specific preventive strategies required for BRONJ. The manuscript has been amended by track changes on page 11 and 12 to clarify this matter further.
Page 13: it would be worthwhile to elaborate a bit about the MUR and NMS Services for the non-UK reader, as an international audience might be somewhat at loss here.
RESPONSE: Thank you for this suggestion. A further explanation of these services has been provided in the text. The MUR and NMS services are both Advanced Services within the NHS Community Pharmacy Contractual Framework in England. An MUR is a structured, adherence centred review of patients prescribed multiple medicines and the NMS service provides support for patients with long-term conditions that"s have been newly prescribed a medicine. Changes to the manuscript to explain these services in more detail have been made on page 12 and 14 using track changes.
Discussion:
In your "Summary of main findings" section, you mention the lack of inter-professional communication as a key issue/barrier (line 50 ff). But how could more communication -although always desirablealleviate the problem of low awareness for this comparably rare complication?
RESPONSE: Thank you for this valid point. Of course, without awareness of the problems communication would not help. Participants did, however, report a general lack of communication between the professions; if awareness of the problem improved, this lack of communication was still seen by participants as a potential barrier for collaborative management of these patients. The text has been amended to explain this point and updated via track changes on page 16.
You also state "…patient reluctance to attend the dentist and difficulties in accessing dental services were thought to be potential barriers for patients." But as awareness seems to be the key issue to me: why should a patient attend the dentist or even think about doing so, if neither his GP nor his pharmacists tells him about the necessity to do so, as they may not think about the complication or consider it unimportant?
RESPONSE: We agree, and it is clear that increased awareness is the first step. This reluctance to attend the dentist and difficulties accessing services is a much more general comment on the population and not specifically linked to BRONJ prevention. Participants discussed that they find some patients reluctant to attend a dentist at any time, and getting this group to attend if prescribed a bisphosphonate could be challenging. We have updated the manuscript using track changes on page 16 to expand on this point further.
In the "Comparison with existing literature" section, you mention the general awareness of your patient population compared with Masson et al. (2009) . But as you informed your patients before the study, this is not really comparable to Masson`s data, and you should avoid talking about "In Comparison…" for something that cannot be compared.
RESPONSE: Thank you. We have updated the manuscript via track changes on page 17 to remove the words "in comparison"
In the same section, you talk about a study from Japan in which 62% of physicians did not request oral examinations before commencing bisphosphonate therapy. This is interesting, as it means that actually 38% of doctors do so in Japan! Compared to the low awareness reported by Masson et al., Japanese doctors seem to think about BRONJ much more often. Why is this? RESPONSE: This is a really interesting point and it is not completely clear from the literature why this is the case. The population investigated in the Japanese study were all physicians who were part of the Japan Osteoporosis Society and as such one could assume that due to this special interest are well informed and experienced in the management of osteoporosis and therefore the prescribing of bisphosphonates. The authors of the papers also identified that their study could potentially have suffered due to selection bias and the low response rate. It would be of interest to explore these differences further in future work on this subject. The manuscript has been updated via track changes on page 18 to discuss this study further.
It might also be worthwhile to include and discuss some more literature concerning other areas of physician-pharmacist collaboration, as there is a considerable body of international literature on this topic. Examples from other countries than the UK might also add more appeal for the international reader.
RESPONSE: We agree that there is a considerable body of international literature on this subject, however after discussion amongst the research team we feel that this is beyond the scope of this paper at this time, and would also greatly lengthen the manuscript, and may be more suited to a review paper in the future.
Limitations
RESPONSE: Thank you, yes, we agree and have updated the manuscript with track changes to reflect this on page 19.
Conclusion "…the incidence of BRONJ is likely to increase; this will continue to be the case unless changes are made to current practice and effective preventive measures are implemented". This statement sounds as if most cases of BRONJ would be potentially preventable -is this really true? As I mentioned above, it would be helpful to get some information about the actual effectiveness of preventive measures like dental care.
RESPONSE: Track changes have been made in the introduction and references to include studies that provide evidence of a reduced incidence rate with preventive measures. As the literature to support the preventive strategies is limited and although advised by guidelines, the recommendation that further research to assess the effectiveness of such interventions has been added to the conclusion using track changes on page 20-21.
Reviewer: 2
Unfortunate that the sample size is small, but, hopefully, dissemination of the findings will stimulate interest in larger studies on dental/pharmacy interprofessional working.
RESPONSE: Thank you for the supportive comments. Although the sample size is small, it is consistent with the qualitative research methodology that was adopted in this study. We agree that hopefully this paper will help to stimulate research into interprofessional working, and see this paper as a significant step forward that will stimulate other researchers to become more active in this research area. We are also actively engaged in such projects and we look forward to disseminating our findings in due course.
Reviewer: 3
Major improvements in terms of writing style, sentence formation, language editing and explanation is suggested. Secondly the sampling number, though mentioned, is very small to analyse and generalize the data. Thirdly the interpretation of the results seems vague.
RESPONSE: Many thanks for taking time to review this paper and provide comments. We have made a large number of changes to the manuscript to address these issues and respond to other reviewer comments using track changes. Furthermore, this research is seeking to illuminate the perspectives of its participants and through an inductive approach produce theories and further research questions. The purpose of the study was not to test hypotheses or provide generalisable data, but to explore the experiences of the individuals; therefore a research methodology utilising a smaller sample size with rich, credible and authentic data was selected. The sample size is similar to other qualitative studies and is supported in the literature (8-24 participants -McCraken, G. 1998. The Long Interview. Newbury Park CA: Sage).
Reviewer: 4
Summary
The present study uses a qualitative approach to assess using semi-structured interview the general practitioners and pharmacists" (n=17 total) attitudes and approach in the prevention of BROJN.
I must admit I am not that familiar with this kind of mixed-methods semi-structured interview studies, but the study seems meticulously planned, analyzed and written. Judging from similar research articles published in the present or other peer-reviewed journals, the methodology used seems to be robust and adequate. Overall I think the present submission is nicely-written and I congratulate the authors on this.
RESPONSE: Many thanks for taking the time to review our papers and thank you for the positive comment.
Comment #1 Please explain all abbreviation at their first mention in every part of the manuscript. For example, the GP abbreviation in abstract is not explained.
RESPONSE:
The manuscript has been amended via track changes to explain abbreviations.
Comment #2
RESPONSE: The gender for each participant has been added to the table. The age of the participant was not captured during the research process; however the number of years of practicing experience is documented and presented in the table.
Comment #3
RESPONSE: Thank you for your comments on this section.
Comment #4
Comment #5
A single comment: due to the nature of the analysis of acquired interviews (subjective selection of specific statements to be included in the text) I believe it could be of merit to interested readers to provide (probably as an online appendix) the full transcripts of all 17 participants. This will enable readers interested in this to further delve in the interviews and probably extract additional information on this subject.
RESPONSE: After discussion with the research team and due to the large volume of raw data, the decision not to publish all transcripts has been made. A sample transcript has been uploaded as a supplementary document.
Reviewer: 5
The study is very important. The use of qualitative methodology added a value to the current research question. However, methodology was not discussed in adequate details to allow guiding other researchers in answering similar questions.
RESPONSE: Thank you for your positive comments. We have expanded the methodology section, to address your comments and those of other reviewers. In order to assist the reader, the interview topic guide has been provided as supplementary document. Interviews were semi-structured and the topic guide was used as a reference and prompt for the researcher. An explanation of the recruitment process has been added to the manuscript on page 7 using track changes. The invitation letter and participant information sheet has been provided as a supplementary document.
Although analysis was adequately explained, questions asked to the sample were not mentioned. Items used in the mini-structure interview were not discussed.
RESPONSE: The topic guide has been added as a supplementary document.
In addition, the authors mentioned that they used purposive sampling but they did not mention which subjects' characteristics they used to select their sample.
RESPONSE: Thank you for your comments here. We have described the sampling strategy in more detail to provide a more accurate description of the process. The strategy would be more accurately described as an initial convenience sample which was followed by a snowball sampling strategy. 
VERSION 2 -AUTHOR RESPONSE
Many thanks for both your's and the reviewer's comments on the manuscript.
We are delighted that the reviewer's have recommended the manuscript for publication and wish to thank them for taking the time with this and previous revisions to assist in improving our paper.
We have made the editorial changes to the manuscript as requested and hope that we have now satisfied your requirements for publication.
